Takeda Pharmaceutical Co Ltd (TKPHF) stock
TKPHFOTCPharmaceutical PreparationsAlso trades as TAK
$39.00+0.36 (+0.93%)
Close on Oct 19, 2026Market cap $134.41BP/E –Yield –
Takeda Pharmaceutical total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Takeda Pharmaceutical's total debt was ¥4.88T at Mar 31, 2026. For fiscal 2026 it was ¥4.88T, up 8.1% from the year before. The highest annual figure on record is ¥5.75T in fiscal 2019.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | ¥4.88T | +8.1% |
| FY2025 | Mar 31, 2025 | ¥4.52T | -6.8% |
| FY2024 | Mar 31, 2024 | ¥4.84T | +10.5% |
| FY2023 | Mar 31, 2023 | ¥4.38T | +0.8% |
| FY2022 | Mar 31, 2022 | ¥4.35T | -6.3% |
| FY2021 | Mar 31, 2021 | ¥4.64T | -9.0% |
| FY2020 | Mar 31, 2020 | ¥5.09T | -11.4% |
| FY2019 | Mar 31, 2019 | ¥5.75T | +483.5% |
| FY2018 | Mar 31, 2018 | ¥985.66B | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026 | Mar 31, 2026 | ¥4.88T | +12.3% |
| Q4 FY2025 | Mar 31, 2025 | ¥4.52T | -2.6% |
| Q4 FY2024 | Mar 31, 2024 | ¥4.84T | -4.9% |
| Q4 FY2023 | Mar 31, 2023 | ¥4.38T | -23.8% |
| Q4 FY2022 | Mar 31, 2022 | ¥4.35T | +340.9% |
| Q4 FY2021 | Mar 31, 2021 | ¥4.64T | – |
| Q4 FY2020 | Mar 31, 2020 | ¥5.09T | – |
| Q4 FY2019 | Mar 31, 2019 | ¥5.75T | – |
| Q4 FY2018 | Mar 31, 2018 | ¥985.66B | – |